🇮🇳🇺🇸🇨🇦 India–North America Corridor Atlas

Why the India–North America corridor matters now

The India-North America corridor is structurally distinctive in two ways that no other AJG corridor shares. (1) It is the world's largest bilateral services trade corridor — Indian IT services exports to the United States alone exceeded USD 45 billion in FY2024 across Infosys, TCS, Wipro, HCLTech, Tech Mahindra, Cognizant (Nasdaq-listed but India-operations-dominant), Mindtree, LTI, plus the second-tier (Mphasis, Persistent, Coforge, Hexaware, Birlasoft, Zensar, Cyient, KPIT). India's USD 56 billion total IT services exports are roughly 80% concentrated in this one corridor. (2) It operates without a Free Trade Agreement — there has never been a comprehensive India-USA FTA, the India-Canada CECA negotiations were suspended in 2023 over diplomatic tensions and remain dormant, and the United States Generalized System of Preferences (GSP) for India lapsed in 2019 removing approximately USD 5.7 billion in preferential market access. The corridor operates on Most-Favoured-Nation (MFN) WTO tariff schedules with bilateral mechanisms (Trade Policy Forum, IPEF — Indo-Pacific Economic Framework, mini-deal exploration) substituting for what would normally be FTA architecture.

Total India-USA bilateral trade reached approximately USD 128 billion in 2024 (roughly USD 62B India-to-USA exports, USD 66B USA-to-India exports — making the USA India's largest single trading partner) growing 10% CAGR. India-Canada bilateral trade is approximately USD 9.5 billion, India-Mexico approximately USD 12 billion. The corridor pipeline on this platform — 220 live mandates — is fourth-largest after India-EU (643), India-ASEAN (370), and India-LATAM (332). Its commercial signature is uniquely JV-led: 34 joint-venture mandates dominate, followed by 27 buy-side, 26 license, and 23 sell-side. This distribution is the inverse of every other AJG continent corridor (where sell-side typically leads) and reflects the corridor's underlying economic logic: in the absence of FTA preferential access, Indian principals partner with American/Canadian principals for joint ownership of operating entities, technology-licensing arrangements, and capital partnerships rather than relying on tariff-arbitraged direct exports.

The 4.5 million Indian-American diaspora is the corridor's people-flow foundation. Indian Americans are the highest-earning ethnic group in the United States (median household income approximately USD 145,000 in 2023 versus US national median USD 75,000), highly concentrated in technology (CEOs at Microsoft, Google, IBM, Adobe, Palo Alto Networks, FedEx, Chanel, Mastercard, Starbucks have been Indian-origin in the recent decade), pharmaceuticals, finance, healthcare, and academia. The 1 million-plus Indian-Canadian diaspora is concentrated in Toronto, Vancouver, Calgary, Montreal. This diaspora density shapes commercial behaviour materially — Indian companies entering the corridor benefit from diaspora-led professional networks, capital introductions, and customer-acquisition advantages that no other corridor offers at this scale. The atlas follows the same nine-W structure as the India-EU, India-GCC, and India-ASEAN atlases.

Who uses the India-North America corridor

The corridor's user base falls into seven structurally distinct cohorts each shaped by the no-FTA, services-dominant, JV-heavy environment. (1) Indian IT services and SaaS principals — the corridor's defining cohort. Top-5 Indian IT services firms (TCS, Infosys, Wipro, HCLTech, Tech Mahindra) collectively employ over 1.5 million people with majority of revenues USA-derived; second-tier Indian IT services and SaaS firms (Persistent, Mphasis, Coforge, Mindtree, LTI, Cyient, KPIT, Sonata, Tata Elxsi, L&T Technology Services) collectively contribute another USD 15-20 billion. The cohort's defining constraint is the H-1B specialty-occupation visa programme — capped at 85,000 annually (65,000 regular + 20,000 master's-degree holders) with India-born applicants typically receiving 70-75% of new H-1Bs — and the L-1 intra-company-transferee visa for senior staff. (2) Indian generic pharmaceutical exporters — the second-largest cohort and operationally distinct from EU-pharma. Indian generics dominate USA generic prescription volume with approximately 40% of USA generics by volume of India origin, USD 8 billion annual exports across Cipla, Sun, Dr Reddy's, Lupin, Aurobindo, Glenmark, Torrent, Cadila Healthcare (Zydus), Biocon, Strides, Ipca Laboratories, and Alkem. The corridor's pharma-specific framework is the Hatch-Waxman Act abbreviated-new-drug-application (ANDA) pathway, FDA Orange Book listings, paragraph-IV patent challenges, and FDA inspections of Indian manufacturing sites (which average 15-20 inspections per major site per year).

(3) Indian engineering and auto-component suppliers — IATF 16949-certified Tier-1 and Tier-2 suppliers feeding into Detroit Three (GM, Ford, Stellantis), Tesla, Toyota North America, Honda North America, BMW North America assembly plants. Bharat Forge maintains USA manufacturing presence; Sona Comstar, Sundram Fasteners, Endurance Technologies are major exporters. (4) Indian D2C, fintech, and B2B-SaaS founders establishing Delaware C-Corp holding structures or Canadian Corp structures to access US/Canada venture capital, IPO pathways, and large-customer markets. The Bangalore-Silicon Valley corridor pair is the most-trafficked entrepreneur corridor globally; Indian-origin founders attract 8-9% of all USA venture capital deployment despite Indian-Americans being only 1.4% of USA population. (5) Indian textiles, apparel, gems-and-jewellery, and home-furnishings exporters — though these are the corridor's commodity-trade cohort, they are smaller in mandate density than EU equivalents because USA tariff structures are less favourable for these categories than EU (where many Indian textiles and apparel goods will receive 0% duty under TEPA when in force). USA imposes 7.5-32% duties on Indian apparel, 5-12% on home textiles, 0-17% on gems and jewellery depending on type. (6) Indian agro and seafood exporters — the seafood cluster (8 of 220 = 3.6% of corridor pipeline) reflects USA being one of India's largest seafood markets with strict FDA inspections; rice (8 of 220) reflects USA Indian-American consumption of Basmati and IR varieties. (7) Indian aerospace and defence partners — Boeing has substantial India sourcing for 737 and 787 platforms; Lockheed Martin partners with Indian defence-PSUs and TATA on F-16 components and other platforms; the Indian-American defence-industrial cooperation deepened materially under the 2008 nuclear deal and post-2018 STA-1 (Strategic Trade Authorization Tier-1) designation. (8) Indian mining, metallurgy, and base-metals exporters — the aluminium cluster at 14 of 220 reflects Hindalco Novelis (Hindalco's USD 6 billion 2007 acquisition of Atlanta-based Novelis remains the largest Indian-corporate USA acquisition).

What flows on the corridor

Services dominate goods uniquely on this corridor — the only AJG corridor where services trade exceeds goods trade in either direction. Services flow India → USA is dominated by IT services (USD 45-50B annually including software development, IT consulting, business-process outsourcing, IT-enabled services), education services (Indian students in USA universities — approximately 270,000 in 2024-25 generating roughly USD 9-10 billion in tuition and living-expense flows), healthcare services (Indian medical doctors and nurses in USA hospitals; Indian-trained physicians are 11% of all USA practising physicians), and engineering and architectural services. Services flow USA → India is dominated by financial services (USA banks, fund managers, and PE/VC firms providing capital and advisory to Indian markets — concentrated in Mumbai's BKC and Bangalore), media and entertainment (Hollywood box-office, streaming-platform content), education services (USA universities with Indian campuses, online MOOCs, executive education), and management consulting (McKinsey, BCG, Bain, Accenture, Deloitte all maintaining substantial India practices but billing the USA-India bilateral component significantly).

Goods flow India → USA is dominated by HS Chapter 71 (gems and jewellery) at approximately USD 11 billion (USA is India's single-largest gems-and-jewellery market — Surat-cut diamonds and Indian gold and silver jewellery), HS Chapter 30 (pharmaceuticals) at USD 8 billion (the Hatch-Waxman ANDA generics dominating), HS Chapter 84-85 (machinery and electronics) at USD 9 billion, HS Chapter 27 (refined petroleum products) at USD 6 billion, HS Chapter 61-62 (apparel) at combined USD 4.5 billion, HS Chapter 03 (frozen seafood) at USD 1.8 billion, HS Chapter 87 (motor vehicles and parts) at USD 2 billion. Goods flow USA → India is dominated by HS Chapter 27 (crude oil and natural gas — USA has been a growing crude supplier to India since 2017 sanctions on Iranian and Venezuelan oil shifted Indian sourcing) at USD 12-15 billion, HS Chapter 71 (rough diamonds and pearls — USA is a major rough-diamond hub for Surat polishing) at USD 6 billion, HS Chapter 88 (aircraft and parts — Boeing deliveries to Indian carriers) at USD 5 billion, HS Chapter 84 (machinery) at USD 6 billion, HS Chapter 26 (ores and concentrates) at USD 1.5 billion. Capital flow is heavily two-way: USA is the largest source of FDI to India (approximately USD 11-13 billion annually) and one of the top-3 destinations for Indian outbound FDI (USD 5-7 billion annually). People flow: USA grants approximately 60,000-65,000 H-1B visas annually to Indian-born applicants plus approximately 80,000 student F-1 visas, plus L-1 intra-company transferees; Indian outbound to Canada is substantial post-USMCA-related Express Entry policy adjustments (Canada admits approximately 130,000 Indians annually as permanent residents). Remittance flow from USA to India was approximately USD 23 billion in 2024 (second-largest source after GCC's USD 35B).

Where the friction points sit

Geographic friction concentrates in five named locations. (1) USA East Coast and West Coast container ports — Indian containerised cargo arrives predominantly at Los Angeles / Long Beach (West Coast Pacific routing — 30-32 sea-days from Mumbai-JNPT via Singapore transhipment), New York / New Jersey (East Coast Atlantic routing via Suez or via Pacific-USA-rail — 22-26 days), Houston (Gulf Coast for petrochemical and Texas-Mexican-border distribution), Savannah and Charleston (rapidly growing East Coast alternatives). USA Customs and Border Protection (CBP) operates a sophisticated Automated Commercial Environment (ACE) system that handles most documentation electronically; physical-inspection rates are approximately 2-4% of containers but inspection-selected containers can experience 7-14 day clearance delays. (2) Canadian ports — Vancouver (Pacific) and Halifax (Atlantic) handle Indian cargo with 28-30 days and 24-26 days respective transit times; Canada Border Services Agency (CBSA) operates the Single Window Initiative since 2020 with similar physical-inspection rates to USA. (3) Indian-side departure ports — Mumbai-JNPT dominates volume to USA East Coast, Mundra and Pipavav (Gujarat) for higher-volume bulk and West-Coast-bound, Chennai for select USA-routed cargo via Singapore-transhipment.

Regulatory friction concentrates in five structural areas distinctive to USA. (4) USA Food and Drug Administration (FDA) inspections of Indian manufacturing sites — for pharmaceuticals, this is the single most important compliance dimension. FDA inspects Indian manufacturing facilities approximately 100-150 times annually with site-specific frequency depending on product category and inspection history. FDA Form 483 observations and warning letters can suspend USA-bound shipments (and have done so for multiple major Indian pharma sites including Sun Pharmaceutical's Halol facility, Cipla's Goa facility, Dr Reddy's various sites historically). The FDA Generic Drug User Fee Amendments (GDUFA) regime imposes user fees on Indian generics submitting ANDAs and registering manufacturing sites — substantial recurring cost requiring careful financial planning. (5) USA International Trade Administration (ITA) anti-dumping and countervailing-duty investigations — Indian steel, aluminium, certain chemicals, certain pharmaceuticals have all faced AD/CVD investigations. Active or recent investigations affect Indian iron-and-steel pipe products, certain pharmaceuticals, and selected agro categories; investigations can impose 10-200%+ duties for periods of 5+ years before sunset review.

(6) USA International Traffic in Arms Regulations (ITAR) and Export Administration Regulations (EAR) — for any Indian principal involved in defence-adjacent technology, dual-use technology, or restricted-end-use destinations, USA export controls apply with substantial penalty exposure. India's STA-1 status (granted 2018) has eased many EAR licensing requirements but ITAR controlled items still require State Department licensing. (7) USA Foreign Corrupt Practices Act (FCPA) extraterritorial enforcement — applies to all transactions involving USA jurisdictional nexus including USD-denominated transactions cleared through USA banks. Indian principals operating in the corridor must implement FCPA-compliant anti-bribery and books-and-records practices. (8) USA-India Trade Policy Forum (TPF) cycle — the bilateral consultation mechanism that has substituted for FTA progress since 2010. TPF meets approximately annually with Trade Working Group sub-meetings quarterly; significant tariff and non-tariff disputes have been negotiated through TPF including USA's removal of Indian aluminium and steel from Section 232 tariffs in 2023, India's removal of retaliatory tariffs on USA almonds, walnuts, apples, lentils, and chickpeas the same year.

When the optimal windows are

Trade-cycle timing on the India-North America corridor follows three overlapping calendars. (1) Indian financial year: April-March, with standard DGFT scheme calendar. (2) USA federal fiscal year and procurement calendar: October-September. The fiscal-year-end September is typically a heavy procurement-acceleration window as USA federal agencies exhaust unused budgets. The H-1B visa cap-cycle is calendar-year-anchored: the H-1B lottery registration opens in March for the October fiscal-year-start, with selected petitions filed April-June and visas active October onward. Indian IT services firms time their recruitment, training, and client-deployment cycles around this annual rhythm. The OPT (Optional Practical Training) cycle for Indian student F-1 graduates aligns with USA university graduation dates (May-June primarily, December secondarily). USA tax-year: calendar-year for individuals, varies for corporates. April 15 individual tax-filing deadline drives substantial mid-Q2 financial-services activity. USA holiday clusters: Thanksgiving week (late November), Christmas-New Year (mid-December to early-January) — combined approximately 4 weeks of materially reduced commercial activity.

(3) Sector-specific seasonal patterns: USA pharmaceutical procurement runs continuously but FDA Office of Generic Drugs ANDA approvals cluster around quarter-end (March, June, September, December) as user-fee-target dates concentrate; Indian pharma earnings calendars must align with USA-distributor inventory cycles. USA fashion/apparel buying cycles (Spring-Summer collections placed October-December for delivery January-March; Fall-Winter placed April-June for delivery July-September) drive Indian textile and apparel exporter calendars. USA construction season (April-October peak) drives demand for Indian aluminium, steel, and engineering goods. USA holiday consumer-electronics buying season (Black Friday late November through Christmas) drives Indian-made consumer goods exports October-November. The major USA trade events drive commercial-meeting density: CES Las Vegas (January), Magic Las Vegas Apparel (February + August), JCK Las Vegas Jewellery (June), SEMA Las Vegas Auto (November), BIO International Convention (June, rotating cities), RSA Conference San Francisco (April or May, cybersecurity), HIMSS Healthcare IT Conference (March, rotating). Optimal-window strategic insight: February-May and September-November are the highest-density commercial windows — clear of the December-January year-end vacuum, the late-June through early-August summer-vacation slowdown, and the Thanksgiving cluster.

Why no FTA — and what fills the gap

The India-USA "no FTA" reality has structural causes that an Indian principal entering the corridor must understand to navigate it. (1) USA's domestic-political constraints — comprehensive FTAs require Trade Promotion Authority (TPA, sometimes called "fast track") which Congress has issued infrequently and which expired in 2021 without renewal. Without TPA, FTA negotiations face Senate amendment risk that makes them politically unfeasible. (2) Structural India-USA differences — the dispute clusters historically include: agricultural market access (USA dairy, almonds, apples, walnuts, soybeans facing Indian tariffs and SPS barriers), pharmaceutical IP (USA preference for stronger patent protection beyond TRIPS minimums versus India's TRIPS-compliant but generics-favouring patent regime), digital trade and data localisation (Indian Personal Data Protection Bill and data-localisation rules versus USA preference for free cross-border data flows), e-commerce and digital services taxation (India's 2% Equalisation Levy on non-resident e-commerce operators), and labour and environment chapter standards. (3) Both governments' preference for "mini-deal" approach — rather than comprehensive FTA, both sides have historically preferred narrow agreements addressing specific irritants: removal of Indian retaliatory tariffs on USA agricultural products in exchange for resolution of specific Indian export constraints; USA's restoration of Indian access to selected agricultural markets in exchange for Indian medical-device tariff cuts. The Trade Policy Forum is the mechanism for these mini-deals.

What fills the FTA gap structurally? (4) USA Generalized System of Preferences (GSP) — historically provided India duty-free access on approximately 1,900 product categories worth USD 5.7 billion in Indian exports, lapsed in 2019 over digital-trade and dairy/medical-device disputes, and remains lapsed without renewal. Indian principals previously relying on GSP-preferential pricing have had to absorb tariff costs or pass them through. (5) USA-India Defence Trade and Technology Initiative (DTTI) — provides bilateral defence-industrial cooperation framework outside the FTA architecture; substantially advanced under the 2018 Communications Compatibility and Security Agreement (COMCASA), 2020 Basic Exchange and Cooperation Agreement (BECA), and 2023 INDUS-X bilateral defence-startup partnership. (6) Indo-Pacific Economic Framework (IPEF) — launched 2022 by USA covering 14 Indo-Pacific economies including India under four pillars (Trade, Supply Chain, Clean Economy, Fair Economy). India joined IPEF for three pillars but excluded itself from the Trade pillar. IPEF Supply Chain Agreement entered into force in February 2024; commercial implications for Indian principals are emerging. (7) Critical Minerals Memorandum of Understanding (October 2023) — bilateral framework for cooperation on lithium, cobalt, nickel, manganese, rare earths supply chains. (8) Initiative on Critical and Emerging Technology (iCET) launched January 2023 — covers AI, semiconductors, biotechnology, clean energy, defence, space cooperation. The aggregate effect: while no comprehensive FTA exists, the corridor is densely overlaid with sector-specific cooperation frameworks that fill specific commercial gaps. The AJG tools suite includes FTA-eligibility calculators that adapt to the no-FTA + bilateral-framework situation.

Which HS chapters dominate the corridor

By value, the top India-to-USA export chapters in 2024-25 were HS 71 (gems and jewellery) at approximately USD 11 billion — the corridor's largest goods-trade category and roughly equal to USA gems-jewellery imports from any other source; HS 30 (pharmaceuticals) at USD 8 billion (Indian generics dominating USA prescription volume); HS 84-85 (machinery and electronics) at USD 9 billion; HS 27 (refined petroleum products) at USD 6 billion; HS 61-62 (apparel) at combined USD 4.5 billion; HS 87 (motor vehicles and parts) at USD 2 billion; HS 03 (frozen seafood) at USD 1.8 billion. The same chapters in reverse direction — USA-to-India — show HS 27 (crude oil and natural gas) at USD 12-15 billion (the corridor's largest USA-export category since 2017); HS 71 (rough diamonds for Surat polishing) at USD 6 billion; HS 88 (aircraft and parts) at USD 5 billion (Boeing 737 MAX, 787 Dreamliner, P-8I maritime patrol deliveries to Indian carriers and Indian Navy); HS 84 (machinery) at USD 6 billion; HS 26 (ores and concentrates) at USD 1.5 billion. India-Canada bilateral chapters add: HS 31 (potash fertilisers, Indian agricultural sector's largest single import category from Canada), HS 47 (wood pulp), HS 74 (copper), HS 88 (aircraft and parts including Bombardier).

The mandate distribution on this platform reflects the corridor's specific commercial pattern: the top eight verticals on India-North America are Aluminium, Iron · Steel · Metals, Seafood, Pharmaceuticals, Rice, IT Products, Footwear, Diamonds — note the prominence of aluminium (14 of 220 = 6.4% of corridor pipeline reflecting the Hindalco-Novelis lineage and ongoing aluminium-sourcing relationships), iron-steel-metals (10 of 220), seafood/pharma/rice/it-products/footwear all at 8 mandates each (3.6% of pipeline each), and the long tail of diamonds/biotech/chemicals at 6 mandates each. The JV-led mandate pattern (68 of 220 = 31%) clusters in technology partnerships (Indian SaaS firms partnering with USA distribution), pharmaceutical generics (Indian-USA JVs around ANDA filings, manufacturing-site cross-investments, supply-chain partnerships), specialty chemicals (Indian intermediate manufacturers in JV with USA brand owners), and aerospace (Indian forging and machining JVs with Boeing, GE Aerospace, Pratt & Whitney). The AJG sub-verticals atlas maps the full taxonomy; the India-NA mandate board view filters the live registry to this corridor; the bilateral pages India-USA and India-Canada cover deeper bilateral context.

Whose regulatory bodies matter

Three regulatory layers operate. India side: same as for other corridors — DGFT, RBI under FEMA, CBIC, FSSAI, DCGI/CDSCO, BIS, MPEDA, APEDA, plus Export Promotion Councils (Pharmexcil, EEPC India, GJEPC, Council for Leather Exports, Coffee Board, Tea Board, Spices Board) and the new emphasis on BIS (Bureau of Indian Standards) Quality Control Orders covering 1,000+ product categories with mandatory ISI-mark certification before export — many USA-bound Indian goods now require BIS pre-export clearance. USA side: US Trade Representative (USTR) for trade-policy negotiations and Section 301 investigations; US Department of Commerce — International Trade Administration (ITA) for anti-dumping and countervailing-duty investigations; US Customs and Border Protection (CBP) for import procedures; Food and Drug Administration (FDA) for pharmaceuticals (CDER for human drugs, CDRH for medical devices, CBER for biologics, CFSAN for food and cosmetics, CVM for veterinary); US Department of Agriculture (USDA) for agricultural products and APHIS for animal-and-plant phytosanitary; Environmental Protection Agency (EPA) for chemicals, pesticides, and environmental compliance under TSCA and FIFRA; Federal Communications Commission (FCC) for telecom and electronics; National Highway Traffic Safety Administration (NHTSA) for automotive products; Office of Foreign Assets Control (OFAC) for sanctions compliance.

Canada side: Global Affairs Canada for trade policy and investment promotion; Canada Border Services Agency (CBSA) for customs; Health Canada for pharmaceuticals and medical devices (operating the Drug Master File system parallel to USA's); Canadian Food Inspection Agency (CFIA) for food and agricultural products; Innovation, Science and Economic Development Canada for industrial regulation. Mexico side: Servicio de Administración Tributaria (SAT) for customs; COFEPRIS for pharmaceuticals and medical devices; SENASICA for agricultural products. USMCA bloc-level: the United States-Mexico-Canada Agreement (in force July 2020, replacing NAFTA) operates internally to the three USMCA parties and does NOT extend external preferences to India — Indian goods entering USMCA face each member's normal MFN tariffs. USMCA's relevance for Indian principals is operational: cross-USMCA distribution of Indian goods (e.g. Indian automotive components manufactured in Mexico and shipped to USA) can benefit from USMCA internal preferences subject to rules-of-origin compliance. The AJG Desk tracks USA, Canada, and Mexico authority sources with daily-refresh cadence.

Whom to actually contact

For commercial counterparty introductions: India side, the relevant Export Promotion Council typically maintains USA-specific Buyer-Seller Meet calendars and trade-mission programmes — Pharmexcil leads CPHI North America (April or May, Philadelphia) and BIO International Convention; GJEPC leads JCK Las Vegas; EEPC India leads SEMA Las Vegas, IMTS Chicago, and OTC Houston; AEPC leads Magic Las Vegas. India Brand Equity Foundation (IBEF) maintains India-USA-specific sectoral reports; FICCI's USA Chapter and CII's North America operations coordinate higher-level bilateral engagement. USA side: US-India Business Council (USIBC) housed at US Chamber of Commerce — the premier bilateral commercial body with named-officer contact for sector-specific Indian principals; US India Strategic Partnership Forum (USISPF) as an alternative bilateral channel; SelectUSA at US Department of Commerce for inbound-USA investment promotion (annual SelectUSA Investment Summit at National Harbor each June); Asia America Hotel Owners Association (AAHOA) for the substantial Indian-American hospitality industry sub-sector. Canada side: Canada-India Business Council in Toronto; Indo-Canada Chamber of Commerce in Toronto and Vancouver; Invest in Canada federal investment-promotion agency.

For regulatory and compliance contact: USA-side contacts include the Commercial Section at the Embassy of India in Washington DC and the Consular Sections at NYC, San Francisco, Chicago, Houston, Atlanta covering different geographic territories. FDA interactions: pre-submission meetings, ANDA pre-submission discussions, and post-inspection responses are critical compliance activities — Indian pharma firms typically engage USA-based regulatory consulting firms (Lachman Consultants, Camargo, Rondaxe, ProPharma Group) for FDA-facing work. USA market entry: state-level economic-development authorities — Texas's Office of the Governor Economic Development & Tourism, Florida's Enterprise Florida, Georgia's Georgia Department of Economic Development, North Carolina's Economic Development Partnership — actively recruit Indian investors. Texas and Georgia are particularly active in courting Indian principals. Banking and trade finance: USA banks with substantial India practices include J.P. Morgan, Citibank, Bank of America, Wells Fargo, Goldman Sachs (institutional). Indian banks with substantial USA branches include SBI (New York and California), HDFC Bank, ICICI Bank, Axis Bank — all maintaining USA correspondent banking relationships. Both AJG principals — Vinod Kumar Jain in Panchkula India and Amit Jain in Lisbon EU — coordinate India-NA mandate qualification through their network density; the corridor's Indian-American diaspora introductions multiply network reach materially. Contact details on the contact page; corridor-specific WhatsApp at +91 98881 47147.

How transactions flow end-to-end

A representative end-to-end documentation stack for an Indian-pharma sell-to-USA mandate runs as follows. (1) Pre-mandate qualification: Indian seller WHO-GMP (CDSCO licence) plus USA-specific compliance — FDA establishment registration (each manufacturing site registered annually under FDA Form FDA 2656), Drug Master File (DMF) filing for API or excipient (Type II for active substance is the most common Indian filing — current backlog is 18-30 months for review), Abbreviated New Drug Application (ANDA) filing for finished-dose generic (review timeline 30 months under standard GDUFA goal), USA Patent Office paragraph-IV certification if challenging an innovator's listed patents triggering a 30-month stay and Hatch-Waxman litigation. (2) Mandate origination at AJG: AJG sources the USA buyer (typically a generic-distributor, hospital-system group purchasing organisation, or pharmaceutical wholesaler — the Big-3 wholesalers AmerisourceBergen / Cardinal / McKesson account for approximately 90% of USA prescription drug distribution), qualifies under Three-P framework, executes mutual NCNDA with explicit FCPA-compliance language, then introduces. (3) Commercial negotiation: technical specifications must include USA-specific labelling (English with USA pharmacopoeial standards USP/NF where applicable), volume commitment, Incoterms (typically CIF Newark/JFK air-freight for high-value time-sensitive pharma, CIF New York/New Jersey for sea-freight; FOB Mumbai or Chennai for buyer-collection), payment terms (LC at sight first 3-6 shipments, ACH or wire-transfer thereafter — USA banking convention is more digital and faster than EU or GCC).

(4) Pre-shipment: Indian seller raises pro-forma invoice in USD, files Shipping Bill via DGFT online portal, obtains pre-shipment inspection certificate, provides Certificate of Analysis with full impurity profile (USA buyers typically require more granular impurity data than EU), files RoDTEP claim. (5) Documentation: commercial invoice (USD), packing list, bill of lading or airway bill, certificate of origin (no preferential FTA so standard non-preferential CoO sufficient — note that the absence of FTA simplifies CoO compared to EU's TEPA-Form complexity), phytosanitary certificate for plant-origin products (USDA APHIS requirements), FDA prior-notice for food shipments, Toxic Substances Control Act (TSCA) certification for chemical shipments. (6) Sea or air transit: Mumbai-NY 22-26 days CIF sea-freight; Mumbai-LA via Singapore transhipment 30-32 days; air-freight Mumbai-NY 1-2 days, Mumbai-LA 1-2 days. (7) USA customs entry: CBP files entry through ACE system, FDA performs Prior Notice review for food (electronic), duty assessment based on HTSUS classification, container release typically same-day for clean documentation. Physical inspection if selected — typically 2-4% rate but can extend release by 7-14 days. (8) Post-shipment: Indian seller files BRC within 9 months per FEMA, processes RoDTEP scrip credit, handles any FDA Form 483 follow-ups or recall procedures, updates AJG mandate to "delivered" status which begins 24-month commission tail. (9) Ongoing relationship management: USA commercial relationship maintenance has substantial in-person component — Indian pharma typically visits USA buyers/wholesalers quarterly minimum, plus participation in major USA pharma events (CPHI North America, BIO International, RxLifeSciences); USA buyers conduct site audits at Indian manufacturing facilities annually or more frequently; Indian principals often establish USA-based subsidiary or representative office once corridor volume justifies (typical break-even at USD 5-10M annual USA revenue).

Live mandate snapshot · India-North America corridor

110 mandates live on the India-North America corridor as of v220.0 ship date. The transaction-type split is 34 joint-venture · 27 buy-side · 26 license · 23 sell-side — uniquely JV-led at 31% of pipeline. This pattern is the inverse of every other AJG corridor (where sell-side leads) and reflects the corridor's no-FTA economic logic: in the absence of preferential tariff access, Indian and American/Canadian principals partner via joint ventures, technology licensing, and capital partnerships rather than relying on direct exports. Top vertical concentrations:

The full filterable board view is at /mandates/c/india-north-america/ · the cross-vertical aggregate at the main Mandate Board. Submission of new mandates on this corridor goes through the standard mandate-submit form with NCNDA-protected qualification before any party introduction. The corridor's notable density in aluminium, iron-steel, seafood, pharma, rice, IT products, footwear, diamonds, biotech, and chemicals reflects the diverse goods-and-services trade pattern with services dominating the bilateral economic relationship while goods trade remains substantial.

Cross-references — corridor context across the platform

The India-North America corridor surfaces in the wider platform across three layers. (1) Touchpoints: every one of the homepage's 22 touchpoints carries India-NA-specific content — Study covers USA universities (Ivy League, MIT, Stanford, Berkeley, top public flagships), USA F-1 student visa pathway, optional practical training (OPT), STEM OPT extension; Nomad covers H-1B, L-1, O-1, EB-1, EB-5, Canadian Express Entry, Provincial Nominee Programs; Jobs covers USA employment-visa regimes; Trade covers no-FTA architecture, Trade Policy Forum, IPEF, GSP-lapsed status; Business covers Delaware C-Corp setup, LLC formation, Canadian Corp structures; Cost covers New York/SF/Boston/LA/Chicago/Toronto/Vancouver PPP comparisons; Visa covers all USA and Canadian visa categories; Economics covers macro indicators; Desk covers USA/Canada authority source tracking. (2) Atlases and bilaterals: USMCA bloc page (3 members · in force July 2020), India-USA TPF page (No FTA), India-Canada CECA (Suspended), India-USA bilateral corridor, India-Canada bilateral corridor, USA, Canada, Mexico location pages.